Leading experts in Molecular Imaging and Nuclear Medicine advising MILabs
Prof. Otto C. Boerman
Otto C. Boerman studied Chemistry at the University of Nijmegen where he also was a junior investigator at the Department of Cell Biology. As a fellow of the Dutch Cancer Society he worked at the Center for Molecular Medicine and Immunology in Newark (NJ) and at the Biological Response Modifiers Program of the National Institutes of Health in Frederick (MD). His preclinical research group in Nijmegen focuses on radionuclide imaging and therapy with radiolabeled peptides and antibodies. He is a member of the editorial board of The Journal of Nuclear Medicine and The European Journal of Nuclear Medicine & Molecular Imaging. He is a (co-)author of more than 300 peer reviewed scientific publications.
Prof. Rudi A. Dierckx
Rudi Dierckx heads the Department Head of Nuclear Medicine and Molecular Imaging at the University Medical Center of Groningen (UMCG). His research is focused on the development of new nuclear imaging methods and radiopharmaceuticals, and the evaluation of existing procedures. Next to being specialized in Nuclear Medicine Prof. Dierckx is also a trained Neuropsychiatrist and has a Master’s degree in Business Administration.
Prof. Sanjiv S. Gambhir
Sanjiv Gambhir is the Virginia and D.K. Ludwig Professor in Cancer Research, Chairman of the Department of Radiology at Stanford University School of Medicine, and a professor by courtesy in the departments of Bioengineering and Materials Science and Engineering at Stanford University. He serves as the Director of the Molecular Imaging Program at Stanford (MIPS) and Canary Center at Stanford for Cancer Early Detection. His laboratory has developed fundamental new ways to image living subjects including methods to image gene expression and cell trafficking. He has developed methods to image signal transduction pathways including protein-protein interactions and other fundamental cellular events. He has translated novel molecular imaging strategies using reporter genes for pilot trials. He played a major role in obtaining reimbursement for FDG PET from the Centers for Medicare and Medical Services.
Prof. G. Allan Johnson
Dr. G. Allan Johnson is the Charles E. Putman University Professor of Radiology, Physics, and Biomedical Engineering. Dr. Johnson received his PhD from Duke University in 1974 in electron spin resonance under Walter Gordy and has been in the Department of Radiology since 1974, where he is currently Director of Diagnostic Physics. He holds joint appointments in Radiology, Physics, and Biomedical Engineering, and he is co-author on over 300 peer-reviewed papers. Dr. Johnson is involved in both the engineering physics required to extend the resolution of MR imaging and in a broad range of applications in the basic sciences.
Prof. Robert F. Mudde
Robert Mudde is currently vice-dean and director of education of the Faculty of Applied Sciences of Delft University of Technology. He holds a chair in Multiphase Flows and specializes on measuring techniques for dense dispersed multiphase flows. The research is partly in the field of Chemical Engineering and partly in Oil & Gas flows. He has acted as associate-editor for the International Journal of Multiphase Flow.
Prof. Martin G. Pomper
Dr. Pomper is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He is also a Professor of Oncology and Radiation Oncology and Molecular Radiation Services. He is an internationally recognized leader in molecular imaging research and develops and implements new imaging agents that target cancer and brain disorders. He is the recipient of the William R. Brody Professor of Radiology, a professorship designated for a radiologist physician scientist who excels in translational innovation in imaging. Dr. Pomper’s interests are in the development of new radiopharmaceuticals, optical probes and techniques for molecular imaging of cancer and central nervous system disease. He is the Editor-in-Chief of the journal Molecular Imaging.
Prof. Vesna Sossi
Vesna Sossi is a Professor in the Physics and Astronomy Department at the University of British Columbia (UBC) and Director of the UBC Positron Emission Tomography imaging group. Her research is focused on quantitative PET imaging, algorithms and data modelling and interpretation, with emphasis on neurodegeneration in humans and small animal models of disease. Her work on Molecular Imaging (in particular PET) and application to unravel mechanisms of Parkinson Disease is recognized worldwide e.g. through widely cited publications in Science and high ranked imaging and neuroscience journals.
Prof. Benjamin Tsui
Dr. Tsui did his postdoctoral training at and was on the faculty of the University of Chicago before joining the Department of Biomedical Engineering and the Department of Radiology at the University of North Carolina at Chapel Hill in 1982. His research interest is in medical imaging, particularly in the area of Single-Photon Computed Emission Tomography (SPECT), Positron Emission Tomography (PET), and magnetic resonance imaging (MRI). Specific research projects include imaging theory, Monte Carlo simulation, collimator design, image evaluation, two-dimensional and three-dimensional image reconstruction algorithm development, and quantitative SPECT imaging techniques. He is a PI of 5 NIH and DOD research grants and subcontracts and heads the Medical Imaging Physics Program within the Department of Radiology at Johns Hopkins Medicine.
Prof. Fred Verzijlbergen
Prof. Fred Verzijlbergen is professor in the department of Nuclear Medicine at the Radboud University Medical Centre Nijmegen, the Netherlands. He is the president of the board of the European Association of Nuclear Medicine (EANM) and supervisor of the OECD/NEA (2009 – 2013). From 1982 till 2012 he was head of the department of Nuclear Medicine at the St. Antonius Hospital in Nieuwegein, the Netherlands. Furthermore he was chairman of the Dutch Society of Nuclear Medicine from 2007 until 2011. His research interests include nuclear cardiology and brain SPECT and PET, and imaging and therapy in oncology.